INTELLIPHARMACEUTICS INTL IN's ticker is and the CUSIP is 458173901. A total of 1 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $30,000 | -77.4% | 14,300 | -72.9% | 0.00% | -100.0% |
| Q1 2017 | $133,000 | -24.9% | 52,800 | -15.1% | 0.00% | 0.0% |
| Q4 2016 | $177,000 | +14.2% | 62,200 | -15.1% | 0.00% | 0.0% |
| Q3 2016 | $155,000 | +93.8% | 73,300 | +42.6% | 0.00% | +100.0% |
| Q2 2016 | $80,000 | +70.2% | 51,400 | +124.5% | 0.00% | 0.0% |
| Q1 2016 | $47,000 | +370.0% | 22,900 | +358.0% | 0.00% | – |
| Q4 2015 | $10,000 | +150.0% | 5,000 | +150.0% | 0.00% | – |
| Q3 2015 | $4,000 | 0.0% | 2,000 | +53.8% | 0.00% | – |
| Q2 2015 | $4,000 | -66.7% | 1,300 | -69.8% | 0.00% | – |
| Q1 2015 | $12,000 | -87.2% | 4,300 | -89.6% | 0.00% | -100.0% |
| Q4 2014 | $94,000 | -39.7% | 41,400 | -20.1% | 0.00% | -50.0% |
| Q3 2014 | $156,000 | -13.8% | 51,800 | +9.3% | 0.00% | -33.3% |
| Q2 2014 | $181,000 | +94.6% | 47,400 | +124.6% | 0.00% | +50.0% |
| Q1 2014 | $93,000 | +365.0% | 21,100 | +298.1% | 0.00% | – |
| Q4 2013 | $20,000 | – | 5,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 41,400 | $94,000 | 0.00% |